Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R R Redfield

Showing results (81-90 of 109) with videos related to

Pageof 11
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 16, 2018
Impact of ureteral stricture and treatment choice on long-term graft survival in kidney transplantationE Arpali, T Al-Qaoud, E Martinez, et al.
AIDS (London, England)|February 1, 1996
V3 seroreactivity and sequence variation: tracking the emergence of V3 genotypic variation in HIV-1-infected patientsN L Michael, K E Davis, L D Loomis-Price, et al.
Journal of Virology|March 1, 1995
Human immunodeficiency virus type 1 cellular RNA load and splicing patterns predict disease progression in a longitudinally studied cohortN L Michael, T Mo, A Merzouki, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1991
Prevalence of HIV antibody among a group of paraphilic sex offendersC Di Giovanni, F Berlin, P Casterella, et al.
The New England Journal of Medicine|June 13, 1991
A phase I evaluation of the safety and immunogenicity of vaccination with recombinant gp160 in patients with early human immunodeficiency virus infection. Military Medical Consortium for Applied Retroviral ResearchR R Redfield, D L Birx, N Ketter, et al.
Journal of Virology|September 1, 1992
Examination of sera from human immunodeficiency virus type 1 (HIV-1)-infected individuals for antibodies reactive with peptides corresponding to the principal neutralizing determinant of HIV-1 gp120 and for in vitro neutralizing activityR Q Warren, S A Anderson, W M Nkya, et al.
Science (New York, N.Y.)|July 15, 1988
Type-restricted neutralization of molecular clones of human immunodeficiency virusD J Looney, A G Fisher, S D Putney, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1990
Tracking the spread of the HIV infection epidemic among young adults in the United States: results of the first four years of screening among civilian applicants for U.S. military serviceJ F Brundage, D S Burke, L I Gardner, et al.
JAMA|April 3, 1991
Trends of HIV seroconversion among young adults in the US Army, 1985 to 1989. US Army Retrovirus Research GroupJ G McNeil, J F Brundage, L I Gardner, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1991
Genetic comparison of human immunodeficiency virus (HIV-1) isolates by polymerase chain reactionF E McCutchan, E Sanders-Buell, C W Oster, et al.
Pageof 11

Showing results (81-90 of 109) with videos related to

Sort By:
Pageof 11
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 16, 2018
Impact of ureteral stricture and treatment choice on long-term graft survival in kidney transplantationE Arpali, T Al-Qaoud, E Martinez, et al.
AIDS (London, England)|February 1, 1996
V3 seroreactivity and sequence variation: tracking the emergence of V3 genotypic variation in HIV-1-infected patientsN L Michael, K E Davis, L D Loomis-Price, et al.
Journal of Virology|March 1, 1995
Human immunodeficiency virus type 1 cellular RNA load and splicing patterns predict disease progression in a longitudinally studied cohortN L Michael, T Mo, A Merzouki, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1991
Prevalence of HIV antibody among a group of paraphilic sex offendersC Di Giovanni, F Berlin, P Casterella, et al.
The New England Journal of Medicine|June 13, 1991
A phase I evaluation of the safety and immunogenicity of vaccination with recombinant gp160 in patients with early human immunodeficiency virus infection. Military Medical Consortium for Applied Retroviral ResearchR R Redfield, D L Birx, N Ketter, et al.
Journal of Virology|September 1, 1992
Examination of sera from human immunodeficiency virus type 1 (HIV-1)-infected individuals for antibodies reactive with peptides corresponding to the principal neutralizing determinant of HIV-1 gp120 and for in vitro neutralizing activityR Q Warren, S A Anderson, W M Nkya, et al.
Science (New York, N.Y.)|July 15, 1988
Type-restricted neutralization of molecular clones of human immunodeficiency virusD J Looney, A G Fisher, S D Putney, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1990
Tracking the spread of the HIV infection epidemic among young adults in the United States: results of the first four years of screening among civilian applicants for U.S. military serviceJ F Brundage, D S Burke, L I Gardner, et al.
JAMA|April 3, 1991
Trends of HIV seroconversion among young adults in the US Army, 1985 to 1989. US Army Retrovirus Research GroupJ G McNeil, J F Brundage, L I Gardner, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1991
Genetic comparison of human immunodeficiency virus (HIV-1) isolates by polymerase chain reactionF E McCutchan, E Sanders-Buell, C W Oster, et al.
Pageof 11